Indonesia: Patent

Indonesia's Constitutional Court has reinstated restrictions on patenting second medical uses of known products, reversing a 2024 reform that had opened pathways for such protection. The decision creates a critical distinction for pharmaceutical patent applicants based on filing dates, with applications submitted during the brief window when the restriction was lifted receiving different treatment than those filed after the Court's ruling.

Indonesia’s Constitutional Court (Mahkamah Konstitusi) has reinstated a key provision limiting pharmaceutical patent protection, signaling a renewed commitment to balancing patent rights with public access to medicines. In its ruling to Case No. 255/PUU-XXIII/2025, the court partially granted a petition for judicial review of Law No. 65 of 2024, which had amended the country’s Patent Law, and ordered the restoration of a provision that had excluded certain pharmaceutical inventions from patentability.

印尼政府近期颁布《2026 年第 30 号非税国家收入政府条例》，对法律部下辖各类服务（包括知识产权服务）的官方收费标准作出调整，新标准已于 2026 年 8 月 1 日起正式施行

Standard Essential Patent litigation has intensified dramatically as each new generation of telecommunications standards—from 3G to 4G LTE and now 5G—brings increasingly...

印度尼西亚推出了一项具有开创性的、专门面向中小微企业的知识产权融资计划，标志着该国经济发展取得历史性突破。

Indonesia's Patent Law No. 65/2024 introduced in October 2024 Article 20A, which requires all active patent holders to submit an annual statement of patent implementation.

印度尼西亚的知识产权禁令存在执行困难的问题，但专利诉讼须在 180 天内审结的规定有助于缓解此问题造成的负面影响。本文将说明申请禁令所

Indonesia's Law No. 5 of 1999 regarding the Prohibition of Monopolistic Practices and Unfair Business Competition (the Anti-Monopoly Law) exempts agreements related to IP rights, namely licenses and franchises...

Indonesia's IP injunctions are tough to implement, but 180-day patent actions help. Note covers requirements.